1. Home
  2. CLDX vs PRGS Comparison

CLDX vs PRGS Comparison

Compare CLDX & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • PRGS
  • Stock Information
  • Founded
  • CLDX N/A
  • PRGS 1981
  • Country
  • CLDX United States
  • PRGS United States
  • Employees
  • CLDX N/A
  • PRGS N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PRGS Computer Software: Prepackaged Software
  • Sector
  • CLDX Health Care
  • PRGS Technology
  • Exchange
  • CLDX Nasdaq
  • PRGS Nasdaq
  • Market Cap
  • CLDX 1.9B
  • PRGS 1.8B
  • IPO Year
  • CLDX 2008
  • PRGS 1991
  • Fundamental
  • Price
  • CLDX $24.34
  • PRGS $43.24
  • Analyst Decision
  • CLDX Buy
  • PRGS Strong Buy
  • Analyst Count
  • CLDX 10
  • PRGS 5
  • Target Price
  • CLDX $43.80
  • PRGS $68.00
  • AVG Volume (30 Days)
  • CLDX 866.0K
  • PRGS 550.4K
  • Earning Date
  • CLDX 11-10-2025
  • PRGS 09-29-2025
  • Dividend Yield
  • CLDX N/A
  • PRGS N/A
  • EPS Growth
  • CLDX N/A
  • PRGS N/A
  • EPS
  • CLDX N/A
  • PRGS 1.09
  • Revenue
  • CLDX $2,599,000.00
  • PRGS $940,126,000.00
  • Revenue This Year
  • CLDX N/A
  • PRGS $32.42
  • Revenue Next Year
  • CLDX N/A
  • PRGS $1.44
  • P/E Ratio
  • CLDX N/A
  • PRGS $39.24
  • Revenue Growth
  • CLDX N/A
  • PRGS 31.41
  • 52 Week Low
  • CLDX $14.40
  • PRGS $40.29
  • 52 Week High
  • CLDX $29.05
  • PRGS $70.56
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 44.59
  • PRGS 45.35
  • Support Level
  • CLDX $22.10
  • PRGS $41.53
  • Resistance Level
  • CLDX $26.85
  • PRGS $43.44
  • Average True Range (ATR)
  • CLDX 1.20
  • PRGS 1.17
  • MACD
  • CLDX -0.30
  • PRGS -0.09
  • Stochastic Oscillator
  • CLDX 36.70
  • PRGS 30.20

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About PRGS Progress Software Corporation (DE)

Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.

Share on Social Networks: